Untitled

Jalón, Ángel García de; Álvarez, Pedro Gil; Azúa-Romeo, J.; Borque, Á.; Sancho, C.; Rioja, L.A.

doi:10.1023/a:1025952129438

Cited by 23 publications

(11 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Paratesticular MMs are aggressive neoplasms capable of widespread local involvement as well as lymphatic and hematogeneous metastases [4,8,9]. Recurrence occurs in 60% of patients within 2 years, with a mortality rate of 30% after a median survival of 24 months [4,8].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Malignant Mesothelioma of the Spermatic Cord

et al. 2011

View full text Add to dashboard Cite

Primary tumors arising from the spermatic cord are very rare. Mesothelioma derives from the mesothelial cells lining the serous membrane, such as the pleura, peritoneum, and tunica vaginalis of testis. Paratesticular malignant mesothelioma (MM), which usually presents as a hydrocele or intrascrotal mass, accounts for 0.3% to 1.4% of MMs. MMs of the spermatic cord account for less than 10% of paratesticular MMs. We report a case of MM of the spermatic cord in a 65-year-old man who primarily presented to the hospital with a left inguinal mass. Following the diagnosis after surgery, he was found to have a contralateral right inguinal mass and died in 6 months. Despite their rare occurrence in the spermatic cord, MMs need to be suspected, especially in patients with a history of asbestos exposure.

show abstract

Section: Discussionmentioning

confidence: 99%

“…Recurrence occurs in 60% of patients within 2 years, with a mortality rate of 30% after a median survival of 24 months [4,8]. Surgical options in the inguino-scrotal area as well as an early tumor stage at the time of diagnosis are likely to result in a slightly better prognosis.…”

Section: Discussionmentioning

confidence: 99%

Malignant Mesothelioma of the Spermatic Cord

et al. 2011

View full text Add to dashboard Cite

show abstract

“…Advanced age at diagnosis also represents a significantly worse prognosis and is related to the aggressive course of the disease 9 , 30 , 31. Tumor recurrence occurs in more than 60% of cases over the first 2 years from diagnosis and in more than 90% of cases over the first 5 years from diagnosis 30. The final lethal course is observed in 30% of cases after a median survival of 24 months 1…”

Section: Discussionmentioning

confidence: 99%

Malignant paratesticular mesothelioma

Fonseca¹,

Marques²,

Takahashi³

et al. 2014

ACR

View full text Add to dashboard Cite

Mesothelioma of the tunica vaginalis testis (MTVT) is a rare tumor that usually affects patients after the sixth decade of life. Exposure to asbestos is a known risk factor. Enlargement of the scrotal volume is the most common initial clinical manifestation, and about 15% of cases present metastasis at diagnosis. The treatment relies on surgical resection while the role of adjuvant chemotherapy and radiotherapy remains unclear. The prognosis for patients is generally poor, with a lethal outcome in 30% over a 24-month period. The authors report a case of a 62-year-old patient with the diagnosis of MTVT without a history of asbestos exposure. After surgical treatment, metastatic disease ensued. Chemotherapy was initiated, but could not be continued due to marked and fast clinical deterioration. The authors call attention to the difficulty of early diagnosis of MTVT due to a nonspecific clinical picture, the lack of action by the patient when the scrotal enlargement was first noticed, and the lack of tumor markers. Delayed diagnosis is definitely related to unfavorable prognosis.

show abstract

“…Almost 40% of the patients die from their disease, with a median survival of 24 months [2,4]. Computed tomography scans are recommended for detection of retroperitoneal lymph nodal spread, which is found in 15% of cases [9] and for which retroperitoneal lymphadenectomy may be considered [4,9]. …”

Section: Discussionmentioning

confidence: 99%